Approximately 765 bags of 5% Dextrose Injection (generic name: dextrose 5% in water), an intravenous (IV) solution, have been recalled because the bags may leak. These 50 mL ADD-Vantage Units, distributed by Hospira, INC., were found to have a lack of sterility assurance which can lead to the solution becoming contaminated. Consumers and healthcare providers should check for lot number 4923608 with an expiration date of May 1, 2022.
A leaking IV bag can compromise the sterility of the solution, allowing bacteria or other pathogens to enter the fluid. If contaminated fluid is administered to a patient, it could lead to serious, life-threatening infections.
Drug recall baseline remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.